OAXACA SITE MANAGEMENT ORGANIZATION, SC   Report issue

For profit Phase 2
Founded: Oaxaca Mexico (2009)

Organization Overview

First Clinical Trial
2017
NCT03051451
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

OSMO (OAXACA SITE MANAGEMENT ORGANIZATION, SC)

Active Ingredients

Drugs in Phase 2 Trials (2)

fluoxetine (prozac) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Obesity (Phase 2)

Overweight (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2